These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 675695)

  • 1. Tissue concentrations and the mortality of d-amphetamine in mice: changes associated with the use of diethylaminoethyl 2,2-diphenylvalerate.HCl1.
    James RC; Franklin MR
    Toxicol Appl Pharmacol; 1978 Apr; 44(1):75-80. PubMed ID: 675695
    [No Abstract]   [Full Text] [Related]  

  • 2. [Modification of the triphasic mortality curve of d-amphetamine].
    Garrido García J; Pérez Naranjo J; Martínez Roldán C
    Arch Farmacol Toxicol; 1982 Dec; 8(3):185-8. PubMed ID: 7183249
    [No Abstract]   [Full Text] [Related]  

  • 3. The triphasic amphetamine lethal dose curve in mice and its possible relationship to drug metabolism.
    James RC; Franklin MR
    Toxicol Appl Pharmacol; 1978 Apr; 44(1):63-73. PubMed ID: 675694
    [No Abstract]   [Full Text] [Related]  

  • 4. Blood pressure and heart rate response evoked by p-hydroxyamphetamine and by p-hydroxynorephedrine II. A quantitative assessment of the role of amphetamine metabolites in acute responses evoked by d-amphetamine.
    Simpson LL
    J Pharmacol Exp Ther; 1980 Jun; 213(3):504-8. PubMed ID: 7205614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution and occurrence of amphetamine and p-hydroxyamphetamine in tissues of the rat after injection of d-amphetamine sulfate.
    Danielson TJ; Boulton AA
    Eur J Pharmacol; 1976 Jun; 37(2):257-64. PubMed ID: 954809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species variation with respect to the metabolism and excretion of d-amphetamine and d,l-N-hydroxyamphetamine succinate.
    Danielson TJ; Davis BA; Boulton AA
    Can J Physiol Pharmacol; 1977 Jun; 55(3):439-43. PubMed ID: 884602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of phenobarbital or 2-diethylaminoethyl-2,2-diphenylvalerate on the activation of cyclophosphamide in vivo.
    Field RB; Gang M; Kline I; Venditti JM; Waravdekar VS
    J Pharmacol Exp Ther; 1972 Feb; 180(2):475-83. PubMed ID: 5010684
    [No Abstract]   [Full Text] [Related]  

  • 8. Differences in the availability of d- and l-enantiomers after administration of racemic amphetamine to rats.
    Jori A; Caccia S; de Ponte P
    Xenobiotica; 1978 Oct; 8(10):589-95. PubMed ID: 716470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of dopamine efflux from rat striatal tissue caused by amphetamine and p-hydroxyamphetamine.
    Fischer JF; Cho AK
    Proc West Pharmacol Soc; 1976; 19():179-82. PubMed ID: 995984
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of diethylaminoethyl diphenylpropyl-acetate hydrochloride (SKF-525A) on the norepinephrine-depleting actions of d-amphetamine.
    Clay GA; Cho AK; Roberfroid M
    Biochem Pharmacol; 1971 Aug; 20(8):1821-31. PubMed ID: 4109535
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of l-, d-, and parahydroxy-amphetamine on locomotor activity and wall climbing in rats of different ages.
    Bauer RH
    Pharmacol Biochem Behav; 1980 Aug; 13(2):155-65. PubMed ID: 7413685
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative study of the central effects of M-14012-A and SKF-525-A in rodents].
    Garrido J; Pérez Naranjo J; Martínez Roldán C
    Arch Farmacol Toxicol; 1983 Aug; 9(2):191-202. PubMed ID: 6660935
    [No Abstract]   [Full Text] [Related]  

  • 13. Different effects of pretreatment with 2-diethylaminoethyl-2,2-diphenylvalerate on the mouse liver polysomal disaggregation by dimethylnitrosamine and lasiocarpine.
    Garry VF; Lopez-Corella E; Plapp FV; Chiga M
    Res Commun Chem Pathol Pharmacol; 1972 Jan; 3(1):117-22. PubMed ID: 5030700
    [No Abstract]   [Full Text] [Related]  

  • 14. Absence of alpha-methyldopamine in rat striatum after chronic administration of d-amphetamine.
    Duffield PH; Dougan DF; Wade DN; Duffield AM
    Life Sci; 1982 May; 30(20):1701-5. PubMed ID: 7047966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 2-diethylaminoethyl-2,2-diphenylvalerate hydrochloride (SKF 525-A) on sulphacetamide distribution and excretion in rats.
    Marchand C; Nadeau D
    Br J Pharmacol; 1973 Jan; 47(1):69-76. PubMed ID: 4717021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation of the effects of scopolamine and d-amphetamine on a spontaneous alternation task.
    Kokkinidis L; Anisman H
    Pharmacol Biochem Behav; 1976 Sep; 5(3):293-7. PubMed ID: 996062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The local anesthetic activity of proadifen HCl (2-diethylaminoethyl-alpha,alpha-diphenylvalerate, HCl).
    Guerrero S; Montoya G; Molgó J
    Eur J Pharmacol; 1970 Apr; 10(1):131-4. PubMed ID: 5458979
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of the drug-metabolizing enzymes' induction by 2-diethylaminoethyl-2-2-diphenylvalerate-HCl (SKF 525 A).
    Fernández G; Villarruel MC; Castro JA
    Toxicol Appl Pharmacol; 1978 Nov; 46(2):315-21. PubMed ID: 734661
    [No Abstract]   [Full Text] [Related]  

  • 19. Kinetics and metabolism of amphetamine in the brain of rats of different ages.
    Honecker H; Coper H
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 291(2):111-21. PubMed ID: 1202363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 2-diethylaminoethyl-2.2-diphenylvalerate hydrochloride on the uterotropic action of o.p'-DDT.
    Zeitoun R; Makar AB
    Pharmazie; 1973 Oct; 28(10):673-5. PubMed ID: 4783554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.